Congress seeks files on gp160 vaccine.
D016915:AIDS Vaccines / Q000627:therapeutic use*; D000163:Acquired Immunodeficiency Syndrome / Q000628:therapy; D002986:Clinical Trials as Topic / Q000191:economics; D005380:Financing, Government; D006077:Government Agencies; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use; D014481:United States; D014614:Vaccines, Synthetic / Q000627:therapeutic use
D016915:AIDS Vaccines; D011994:Recombinant Proteins; D014614:Vaccines, Synthetic; C053473:VaxSyn HIV-1 (gp160) vaccine